Structure Therapeutics Inc.
Ticker: GPCR
| Insider | Title |
|---|---|
| Angus C. Russell | Director |
| Ashley Hall | Chief Development Officer |
| Crespo Blas Coll | Chief Medical Officer |
| Daniel G Welch | Director |
| Eric Dobmeier | Director |
| Gp Holdings Llc Bvf | 10% or greater ownership |
| I Gp Llc Bvf | See explanation of responses |
| Ii Gp Llc Bvf | See explanation of responses |
| Inc/il Bvf | 10% or greater ownership |
| Joanne Waldstreicher | Director |
| Jun Yoon | CHIEF FINANCIAL OFFICER |
| Llc Fmr | See Remark 1, 10% or greater ownership |
| Ltd Fil | See Remark 1 |
| Mark Allen Bach | CHIEF MEDICAL OFFICER |
| Mark N Lampert | 10% or greater ownership |
| Melita Sun Jung | Chief Business Officer |
| Partners L P/il Bvf | 10% or greater ownership |
| Partners Os Ltd. Bvf | See explanation of responses |
| Ramy Farid | Director |
| Raymond C Stevens | CHIEF EXECUTIVE OFFICER, Director |
| Sharon Tetlow | Director |
| Ted W Love | Director |
| Value Fund Ii Lp Biotechnology | See explanation of responses |
| Value Fund L P Biotechnology | See explanation of responses |
| Value Trading Fund Os Lp Biotechnology | See explanation of responses |
| Xichen Lin | CHIEF SCIENTIFIC OFFICER |
| Yingli Ma | CHIEF TECHNOLOGY OFFICER |